Since versican V1 and V0 isoforms predominantly increase in tumours of different origin, suggesting that these isoforms are mainly involved in tumour development, we also elucidated whether TGF-β2 differentially modulates the expression of versican isoforms in high-grade glioma. This evidence concerns the gene VCAN and central nervous system cancer.